Testing effectiveness (Phase 2)Looking for participantsNCT05272709What this trial is testingTT-702 in Patients With Advanced Solid Tumours.Who this might be right forAdvanced Solid Tumors Cancer Research UK 60
Testing effectiveness (Phase 2)Looking for participantsNCT03606967What this trial is testingTesting the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Invasive Breast CarcinomaMetastatic Triple-Negative Breast Carcinoma National Cancer Institute (NCI) 86
Early research (Phase 1)Ended earlyNCT01071564What this trial is testingRO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+5 more National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Testing effectiveness (Phase 2)Looking for participantsNCT04501523What this trial is testingA Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBCWho this might be right forTriple-negative Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 460
Not applicableEnded earlyNCT05891197What this trial is testingA Biomarker Screening Protocol for Participants With Solid TumorsWho this might be right forTriple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more Lyell Immunopharma, Inc. 10
Large-scale testing (Phase 3)Study completedNCT04629846What this trial is testingStudy in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.Who this might be right forBreast Cancer Qilu Pharmaceutical Co., Ltd. 517
Testing effectiveness (Phase 2)Study completedNCT02971761What this trial is testingPembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast CancerWho this might be right forAndrogen Receptor PositiveEstrogen Receptor NegativeHER2/Neu Negative+3 more City of Hope Medical Center 18
Testing effectiveness (Phase 2)Ended earlyNCT05113966What this trial is testingTrilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast CancerWho this might be right forTriple Negative Breast Cancer G1 Therapeutics, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT04664972What this trial is testingComparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBCWho this might be right forTriple Negative Breast Cancer Henan Cancer Hospital 212
Testing effectiveness (Phase 2)WithdrawnNCT03872505What this trial is testingPre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast CancerWho this might be right forBreast CancerTriple Negative Breast Cancer Cedars-Sinai Medical Center
Very early researchStudy completedNCT03599453What this trial is testingChemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast CancerWho this might be right forTriple -Negative Breast CancerEstrogen Receptor NegativeHER2/Neu Negative+2 more Roswell Park Cancer Institute 8
Large-scale testing (Phase 3)Active Not RecruitingNCT03997123What this trial is testingCapivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBCWho this might be right forTriple Negative Breast Neoplasms AstraZeneca 923
Testing effectiveness (Phase 2)Study completedNCT01349959What this trial is testingAzacitidine and Entinostat in Treating Patients With Advanced Breast CancerWho this might be right forMale Breast CarcinomaRecurrent Breast CarcinomaStage IIIC Breast Cancer AJCC v7+2 more National Cancer Institute (NCI) 58
Not applicableLooking for participantsNCT07808086What this trial is testingRole of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast CancerWho this might be right forBreast Cancer Istituti Clinici Scientifici Maugeri SpA 30
Early research (Phase 1)Study completedNCT04664829What this trial is testingThe Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBCWho this might be right forMetastatic Triple-Negative Breast Carcinoma National Cancer Centre, Singapore 12
Testing effectiveness (Phase 2)Looking for participantsNCT06165900What this trial is testingStereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBCWho this might be right forStereotactic RadiotherapyImmunotherapyBreast Cancer Shengjing Hospital 136
Testing effectiveness (Phase 2)Study completedNCT03167619What this trial is testingPhase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)Who this might be right forTriple Negative Breast Cancer Duke University 45
Early research (Phase 1)Ended earlyNCT04099277What this trial is testingLY3435151 in Participants With Solid TumorsWho this might be right forSolid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more Eli Lilly and Company 2
Testing effectiveness (Phase 2)UnknownNCT04517292What this trial is testingEribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)Who this might be right forBreast Cancer Fudan University 160